CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results

International Journal of Cardiology

Volumn 117, Issue 3, 2007, Pages 422-424

  Lee, Chi Hang ^a   Low, Adrian ^a   Lim, Jimmy ^a   Wong, Hwee Bee ^a   Lim, Yean Teng ^a   Tan, Huay Cheem ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Bifurcation; CYPHER; Drug eluting stent; TAXUS

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS;

COMBINED MODALITY THERAPY; CORONARY ARTERIOSCLEROSIS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TIME FACTORS;

EID: 33947716906     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.05.065     Document Type: Article

References (9)

1. Moses J.W., Leon M.B., Popma J.J., et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Morice M.C., Colombo A., Meier B., et al. REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
4. Dibra A., Kastrati A., Mehilli J., et al. ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
5. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
6. Mehilli J., Dibra A., Kastrati A., et al. Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
7. Lee C.H., Tan H.C., Wong H.B., et al. Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions-a single-center experience. J Invasive Cardiol 18 (2006) 39-42
8. Lee C.H., Lim J., Low A., Tan H.C., and Lim Y.T. Late Angiographic Stent Thrombosis (LAST) of polymer-based paclitaxel-eluting stent. Heart 92 (2006) 551-553
9. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130